Statement of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income attributable to common shareholders	$ 1,530,946	$ 6,796,695
Adjustments to reconcile net income to net cash used in operating activities net of changes in assets and liabilities resulting from the sales and purchases of subsidiaries:
Amortization (accretion) of investments	(3,197,526)	2,218,898
Realized investment gains, net	(288,811)	(11,238,250)
Unrealized trading gains included in income	(249,992)	281,685
Amortization of deferred policy acquisition costs	42,324	46,536
Amortization of cost of insurance acquired	798,264	859,126
Depreciation	954,827	959,836
Net income attributable to noncontrolling interest	480,342	626,590
Charges for mortality and administration of universal life and annuity products	(5,171,353)	(5,281,297)
Interest credited to account balances	3,893,025	3,725,149
Change in accrued investment income (loss)	288,854	(974,807)
Change in reinsurance receivables	505,768	1,507,932
Change in policy liabilities and accruals	(4,680,614)	(2,422,859)
Change in income taxes receivable (payable)	(3,866,361)	2,259,832
Change in other assets and liabilities, net	3,005,247	(935,954)
Net cash provided by (used in) operating activities	(5,955,060)	(1,570,888)
Proceeds from investments sold and matured:
Fixed maturities available for sale	27,476,702	84,519,249
Equity securities available for sale	528,114	1,287,475
Trading securities	24,017,415	15,344,038
Mortgage loans	15,094,812	4,134,379
Discounted mortgage loans	6,182,319	7,195,550
Real estate	7,301,330	9,499,500
Policy loans	2,758,116	2,782,021
Total proceeds from investments sold and matured	83,358,808	124,762,212
Cost of investments acquired:
Fixed maturities available for sale	(21,602,005)	(122,811,049)
Equity securities available for sale	(8,996,880)	(11,938,273)
Trading securities	(23,105,651)	(12,876,567)
Mortgage loans	(9,986,840)	(17,513,757)
Discounted mortgage loans	(1,455,670)	(6,146,295)
Real estate	(9,404,269)	(9,299,718)
Policy loans	(2,204,016)	(4,194,686)
Payments for (Proceeds from) Other Investing Activities	(25,000)	0
Total cost of investments acquired	(76,780,331)	(184,780,345)
Sale of property and equipment	0	17,440
Net cash used in investing activities	6,578,477	(60,000,693)
Cash flows from financing activities:
Cash received in reinsurance recapture	0	2,480,706
Policyholder contract deposits	4,461,097	4,382,637
Policyholder contract withdrawals	(4,056,584)	(4,664,817)
Proceeds from notes payable/line of credit	0	1,411,000
Payments of principal on notes payable/line of credit	(1,857,954)	(2,827,206)
Purchase of treasury stock	(238,305)	(781,124)
Distributions to minority interests of consolidated subsidiaries	0	(160,000)
Net cash provided by (used in) financing activities	(1,691,746)	(158,804)
Net increase (decrease) in cash and cash equivalents	(1,068,329)	(61,730,385)
Cash and cash equivalents at beginning of period	23,321,246	82,925,675
Cash and cash equivalents at end of period	$ 22,252,917	$ 21,195,290